Researchers compared two rapid tests for detecting a fungal infection called aspergillosis in lung fluid samples. One test uses a simple lateral flow format (like a COVID test), while the other is a more traditional enzyme immunoassay. Both tests had good agreement, with the lateral flow assay showing high accuracy and the advantage of being faster and requiring fewer laboratory resources, making it especially useful for hospitals with limited equipment.